홍성한

All filings by 홍성한 on record concern 비씨월드제약, in the capacity of chief executive. The record holds 13 filings, for trades running from 30 August 2022 to 4 August 2026.

In open-market terms, that means 7 purchases worth €886k on one side and 1 sale on the other. The totals exclude 5 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 3 purchases and no sales.

The median purchase comes to €26k. Relative to company size, the median is 0.14% of market cap (3 purchases with a known value). 2 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -29.7%. These figures describe past trades and do not predict future prices.

Most recently, on 4 August 2026, the filings show a transaction in 비씨월드제약. The latest purchase dates back some time: it was published 187 days ago, on 14 April 2026. Filings reach the DART (FSS) feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.